<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/F794A8EB-CD37-4045-A287-BDE2042CFE88"><gtr:id>F794A8EB-CD37-4045-A287-BDE2042CFE88</gtr:id><gtr:name>Demuris Limited</gtr:name><gtr:address><gtr:line1>23 THE CRESCENT</gtr:line1><gtr:city>WHITLEY BAY</gtr:city><gtr:postCode>NE26 2JG</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F794A8EB-CD37-4045-A287-BDE2042CFE88" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>F794A8EB-CD37-4045-A287-BDE2042CFE88</gtr:id><gtr:name>Demuris Limited</gtr:name><gtr:address><gtr:line1>23 THE CRESCENT</gtr:line1><gtr:city>WHITLEY BAY</gtr:city><gtr:postCode>NE26 2JG</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>22818.0</gtr:offerGrant><gtr:projectCost>32598.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B3E7AE3F-6CE8-4C2B-8BA6-BF6C4C2F3DC3"><gtr:id>B3E7AE3F-6CE8-4C2B-8BA6-BF6C4C2F3DC3</gtr:id><gtr:firstName>Claire</gtr:firstName><gtr:surname>Ellis</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=131954"><gtr:id>EC2C83C1-EFD8-4235-9CE8-BF642E600515</gtr:id><gtr:title>Rapid Genomic Library Generation Feasibility Study</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Feasibility Studies</gtr:grantCategory><gtr:grantReference>131954</gtr:grantReference><gtr:abstractText>New antibiotics are urgently needed to replace those that are lost to increasing antibiotic resistance. Demuris has been using synthetic biology approaches to access these silent or cyptic gene clusters by heterologous production. We have been working to extract the biosynthetic genes from poor- or non-producing donor strains and introducing them to a Superhost, optimised for antibiotic production and its own growth characteristics. We propose new methods that will accelerate discovery and exploitation of previously unseen antibiotics from existing libraries.</gtr:abstractText><gtr:fund><gtr:end>2015-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2015-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>22818</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">131954</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>